Chimeric antigen receptor–based cell therapy for treating urological tumors
Abstract. Urological tumors represent a significant global health challenge, with conventional therapies often proving insufficient to control disease progression. Recent breakthroughs in cellular immunotherapy, particularly in chimeric antigen receptor (CAR)-T cell, CAR–natural killer cell, and CAR...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Wolters Kluwer Health
2025-11-01
|
| Colección: | Current Urology |
| Acceso en línea: | http://journals.lww.com/10.1097/CU9.0000000000000305 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|